SGLT2 Inhibitors and the Risk of Hospitalization for Fournier ’s Gangrene: A Nested Case–Control Study

ConclusionThe study did not find that treatment with SGLT2i, as compared with treatment with two or more non-SGLT2i AHAs or insulin alone, was statistically significantly associated with an increased risk of hospitalization for FG. Additional studies are needed to corroborate the findings.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research